Urotronic launches feasibility trial of drug-coated balloon

Urotronic is launching a feasibility trial of its drug-coated balloon in men with narrowed urethras, according to StarTribune.

The Plymouth, Minn.-based company’s Optilume device is inserted into a patient’s urethra and then inflates to dilate the urethra, allowing urine to leave the patient’s bladder.

Get the full story at our sister site, Drug Delivery Business News.

The post Urotronic launches feasibility trial of drug-coated balloon appeared first on MassDevice.

from MassDevice http://ift.tt/2hqTuBC